Warning! GuruFocus detected
1 Severe warning sign
with MTVA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
MetaVia Inc
NAICS : 325412
SIC : 2834
ISIN : US36870A1088
Description
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 117.77 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 71.4 | |||||
| 3-Year EPS without NRI Growth Rate | 71.7 | |||||
| 3-Year FCF Growth Rate | 72.8 | |||||
| 3-Year Book Growth Rate | -80.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 29.35 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.48 | |||||
| 9-Day RSI | 53.08 | |||||
| 14-Day RSI | 49.41 | |||||
| 3-1 Month Momentum % | -28.08 | |||||
| 6-1 Month Momentum % | -50.17 | |||||
| 12-1 Month Momentum % | -64.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | |||||
| Quick Ratio | 1.94 | |||||
| Cash Ratio | 1.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -326.9 | |||||
| Shareholder Yield % | -149.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -207.19 | |||||
| ROA % | -128.99 | |||||
| ROIC % | -2043.19 | |||||
| 3-Year ROIIC % | -1170.8 | |||||
| ROC (Joel Greenblatt) % | -13705.52 | |||||
| ROCE % | -214.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| EV-to-EBIT | 0.08 | |||||
| EV-to-Forward-EBIT | -0.03 | |||||
| EV-to-EBITDA | 0.08 | |||||
| EV-to-FCF | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 1.71 | |||||
| Price-to-Net-Cash | 1.73 | |||||
| Earnings Yield (Greenblatt) % | 1250 | |||||
| FCF Yield % | -185.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MTVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MetaVia Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.04 | ||
| Beta | 0.33 | ||
| 3-Year Sharpe Ratio | -1.07 | ||
| 3-Year Sortino Ratio | -1.28 | ||
| Volatility % | 54.73 | ||
| 14-Day RSI | 49.41 | ||
| 14-Day ATR ($) | 0.123469 | ||
| 20-Day SMA ($) | 1.545892 | ||
| 12-1 Month Momentum % | -64.04 | ||
| 52-Week Range ($) | 1.29 - 5.3 | ||
| Shares Outstanding (Mil) | 8.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MetaVia Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MetaVia Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MetaVia Inc Frequently Asked Questions
What is MetaVia Inc(MTVA)'s stock price today?
The current price of MTVA is $1.54. The 52 week high of MTVA is $5.30 and 52 week low is $1.29.
When is next earnings date of MetaVia Inc(MTVA)?
The next earnings date of MetaVia Inc(MTVA) is 2025-05-09 Est..
Does MetaVia Inc(MTVA) pay dividends? If so, how much?
MetaVia Inc(MTVA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers